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Abstract 
Anxiety, expectancy induction, and conditioning have been shown to influence placebo analgesic 
responses. This study aimed to investigate the role that state anxiety has in placebo analgesia in a 
conditioning paradigm. The researchers conditioned 28 healthy individuals to relate personalized 
heat pain intensities with color cues representing the effectiveness of a sham external neural 
stimulator device. At the beginning of the study, state anxiety levels were measured. Participants 
were randomly assigned to one of three groups, two experimental placebo groups or a control group 
(CG). Participants in the placebo groups were conditioned and received verbal suggestion, either 
by learning about the nature of the placebo device (open-label placebo; OLP) or not (closed 
placebo; CP). The CG was not conditioned and was given neutral verbal suggestions about the ENS 
device. We hypothesized that a placebo effect would take place in the OLP and CP groups, and 
that the effect would be comparable between the two. We further hypothesized that individuals 
with high state anxiety will experience less placebo effects, and that they would have higher overall 
pain ratings. Lastly, we controlled for anxiety increase. Results and statistical analyses were 
inconclusive, mainly due to the small sample size. The current study, however, is the first in this 
field to incorporate a protocol that takes into account the role of state anxiety in placebo analgesia 
within a conditioning paradigm, while incorporating OLPs and heat pain. This study can thus be 
considered a pilot study. Future research based on the current paper should have a larger sample 
size and make minor modifications. 
Keywords: anxiety, expectancy, conditioning, placebo analgesia, heat pain, ENS, state anxiety, 
placebo, verbal suggestion, open-label placebo, pilot study  
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The Role of State Anxiety in Placebo Analgesia within a Conditioning Paradigm 
The term ‘placebo effect’ can be considered as the response of an individual after the 
administration of a placebo. Evidence has demonstrated the magnitude and significance of placebo 
effects in pain studies (Schedlowski, Enck, Rief, & Bingel, 2015). Placebo analgesia is the 
subjective pain relief following the application of a treatment that is not directly caused by the 
pharmacological aspects of that treatment, but rather by placebo aspects. The placebo effect is 
mediated by the specific psychosocial context surrounding that administration (Benedetti, 2009). 
For example, positive or negative expectations can significantly affect the experience of pain 
(Colloca & Benedetti, 2005). Vase, Robinson, Verne, and Price (2003) argue that the expectation 
of the therapeutic effect under a placebo paradigm may be a fundamental concept underlying the 
placebo analgesic effect, equal to the expectancy theory of placebo effects, which implies that 
belief in the functionality of an administered placebo is crucial in order for placebo analgesic effects 
to take place. In experimental placebo paradigms, a sham treatment (e.g. a pill or a device) is 
usually paired with pain reduction in order to create the expectations of analgesic effects (Price et 
al., 1999).  
Manipulations of both verbal suggestions and conditioning show to positively affect placebo 
analgesia (Finniss, Nicholas, & Benedetti, 2009). A considerable number of placebo analgesia 
studies include conditioning paradigms, which entail pairing a sham treatment with pain intensity 
changes to create an expectation of analgesic effects (Voudouris, Peck, & Coleman, 1985). These 
paradigms, along with manipulations in verbal instructions, have shown to be crucial processes for 
eliciting a placebo effect by decreasing symptoms when administering a placebo treatment 
(Colloca, Klinger, Flor, & Bingel, 2013). Such paradigms consist of acquisition and evocation 
phases. During the acquisition phase, the pairing between an unconditioned stimulus (UCS; e.g., 
heat intensity) and a conditioned stimulus (CS; e.g., visual cue) takes place, leading to a conditioned 
response (CR; e.g., altered level of experienced pain after the presentation of a visual cue 
corresponding with varied heat intensities). In the evocation phase, the CR can be evoked by the 
mere presentation of the CS without the UCS. The result of a conditioning paradigm in the context 
of placebo analgesia would be the conditioned placebo analgesic response.  
The roles of conditioning and expectancy induction through verbal suggestion in the field of 
placebo analgesia show mixed results (e.g., Bąbel et al., 2017; Bartels et al., 2014). For example, 
a study by Voudouris, Peck, and Coleman (1990) indicates that conditioning alone is a powerful 
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method to induce placebo effects, compared to verbal expectancy induction in placebo analgesia. 
However, various studies (e.g., Carlino et al., 2014; Bartels et al., 2014) suggest that it is the 
combined effect of both verbal suggestions and conditioning that has more significant placebo 
effects than sole verbal suggestion and sole conditioning. For example, the pure pairing between 
pain reduction and visual cues combined with verbal suggestions can generate conditioned 
(placebo) analgesic responses. Thus, to increase the magnitude of placebo analgesia, the 
employment of both specific conditioning paradigms and manipulations in verbal instructions can 
be used (Finniss, et al., 2009). 
A variety of cognitive and biological factors have been found to have a moderating role in pain 
perception, such as age (Cook & Chastain, 2001). Alongside (verbal) manipulations and 
conditioning paradigms to affect one’s outcome expectancies, levels of anxiety have also been 
hypothesized to have a role in placebo analgesia. Namely, briefing individuals about impending 
pain has been shown to increase negative emotions, including anxiety, and in turn increase one’s 
perception of pain (Flaten, Alaksen, Lyby, & Bjørkedal, 2011). Researchers differentiate between 
trait anxiety (a person’s general disposition to be anxious) and state anxiety (a person’s current 
level of anxiety, which can be modulated by situational factors) (Spielberger & Krasner, 1988). In 
the current study, we will mainly focus on the relationship between state anxiety and placebo 
analgesia, as state anxiety can affect a variety of aspects of pain perception. For example, Staats, 
Staats, and Hekmat (2001) suggest that state anxiety affects the induction of placebo effects, in 
which low state anxiety decreases pain perception (Evans, 1985). Moreover, heightened levels of 
state anxiety have been shown to lead to a reduction in pain tolerance (Carter et al., 2002) and to 
increased self-reported pain intensities (Jones, Spindler, Jorgensen, & Zachariae, 2002). We will 
study the effects of state anxiety in the situational context of an experimental pain procedure 
making use of conditioning and expectancy induction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
1.1 Open-Label Placebo 
The expectancy theory of placebo analgesia is challenged by demonstrations that placebo 
treatments can still elicit analgesic effects even when individuals are aware of the nature of the 
treatment being technically ineffective (Benedetti et al., 2003). Typically, placebos are delivered 
in a deceptive manner (i.e., closed placebos; CPs), making placebo receivers (e.g., patients of 
chronic pain) unaware of the nature of the placebo treatment. However, a number of studies suggest 
that deception is not required in order to elicit placebo effects (e.g., Carvalho et al., 2016). Evidence 
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shows that long-term placebo effects can be elicited under “open-label” conditions, in which 
individuals are fully informed about the administration of an inert placebo treatment (Blease, 
Colloca, & Kaptchuk, 2016; Charlesworth et al., 2017). These cases allow for the use of placebo 
treatments without ethical constraints such as those that come with deception, and they promote 
patient involvement in clinical settings. Kaptchuk and Miller (2018) hypothesize that open-label 
placebos (OLPs) are valuable for conditions in which placebo responses are substantial and rival 
the active treatment. For example, Hoenemeyer, Kaptchuk, Mehta, and Fontaine (2018), who 
studied OLP treatment for cancer-related fatigue, conclude that OLPs may reduce fatigue symptom 
severity and quality of life in cancer survivors. Promising results arise from research concerning 
OLP in clinical implementation settings, including chronic pain in the lower back (Carvalho et al., 
2016) and irritable bowel syndrome (Kaptchuk et al., 2010). Furthermore, Locher and colleagues 
(2017) compared the effects of CP, OLP, and not receiving any treatment in an experimental heat 
pain paradigm. They conclude that OLP treatments are as effective as CP treatments when 
accompanied by a rationale. It is thus worthy to investigate whether further implementing a 
conditioning paradigm along with differences in knowledge levels over the (placebo) nature of the 
treatment (OLP versus CP) would contribute to the increase of placebo analgesia, taking into 
account individuals’ state anxiety levels. 
1.2 Relevance 
Further exploration of OLPs are of great theoretical and clinical importance. The use of placebo 
treatments is a point of controversy because placebos do not include an active medication to treat 
the condition at hand, because they are thought to be less effective than other treatments, and due 
to the above-mentioned ethical reasons (Colloca & Howick, 2018). This is where OLPs could take 
part, through bypassing a part of the ethical barriers to the use of placebo treatments. In addition, 
it is important to study the potential of OLPs as a therapeutic method, as physicians use placebo 
treatments in routine care (Linde et al., 2018). OLPs can be exploited to treat pain conditions, such 
as fibromyalgia and chronic pain, while diminishing the administration of pharmacological 
substances and the adverse effects accompanying them. Thus, a thorough understanding of the best 
conditions to apply them is of great value.  
Moreover, it is important to identify the ways in which patients’ anxiety levels at the time of 
the treatment (i.e., state anxiety) may affect their responsivity to placebo treatments in order to 
facilitate treatment effectiveness. This can be done through studying the effects of state anxiety on 
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placebo responsivity, taking into account the patients’ knowledge of the nature of the treatment 
(OLP or CP). Understanding the response nature of highly anxious individuals to different types 
of placebo treatments can enhance our knowledge over the most appropriate treatments to be used 
in medical settings and over the best forms of communication methods about placebo treatments 
to this subgroup of patients. While conducting experimental studies with OLPs, an explanation 
about what placebo effects entail are of utmost importance. Providing participants with placebo 
information can function as a simulation between a medical professional and their patients, 
allowing direct translation of the results of the study into clinical practice using (open-label) 
placebo treatments, taking into account the patients’ state anxiety levels during treatment 
application. 
In the present study, we aim to condition healthy individuals to associate pain intensities with 
neutral visual cues (i.e., colors with high or low pain intensities), leading to changes in their pain 
expectancies while receiving a placebo treatment, taking in consideration knowledge over the 
nature of the treatment (open-label or closed) and their personal levels of state anxiety. 
1.3 Hypotheses 
We investigate whether OLPs are as beneficial as CPs in alleviating the intensity of healthy 
individuals’ ratings of their experienced pain. Furthermore, we study the effects of state anxiety on 
individuals’ pain perception and placebo analgesia in a conditioning paradigm, inducing changes 
in pain intensity expectancies. Thus, firstly, we hypothesize that individuals from the placebo 
groups (i.e., OLP and CP) will experience more placebo analgesia when compared to the control 
group (CG). Secondly, we hypothesize that individuals who are informed about the placebo nature 
of the treatment (i.e., OLP group) will experience similar placebo analgesia levels to those who are 
not educated about it (i.e., CP group). Furthermore, we hypothesize that individuals scoring high 
on state anxiety will experience less placebo effects across the three groups. Moreover, we expect 
that overall pain ratings will be higher for individuals scoring high on state anxiety than individuals 
scoring low on state anxiety. Lastly, we control whether state anxiety levels increase at the end of 
the experiment in comparison to the beginning of the testing.  
2. Methods 
2.1 Participants 
Our study included 28 participants (60.7% females) between the ages of 18 and 35 (M = 23.14, SD 
= 2.578), of 16 different nationalities (Figure 1), 17.9% of whom were of German nationality. 
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Individuals were not eligible to participate if they had participated in heat pain-related studies in 
the behavioral and social sciences faculty before (i.e., “Aan de slag!! Pijn studie” and/or “ENS on 
pain and itch”); were experiencing severe physical morbidity; were diagnosed with a psychiatric 
disorder; were suffering from chronic pain; were suffering from injuries on hands/arms; were 
regular users of recreational drugs; and/or were pregnant or breastfeeding. Participants who had 
consumed alcohol and/or pain medication 24 hours prior to the experiment, caffeine and/or nicotine 
three hours prior to the experiment, and/or recreational drugs one week prior to the experiment, 
were exempted from the study. All participants were randomly assigned to one of three groups, 
and were compensated for their participation either financially or with study credits. 
 
 
Figure 1. Pie chart of participant nationalities. 
2.2 Study Design 
This study was a randomized, single-blinded, controlled trial, that included two experimental 
groups (i.e., closed placebo (CL; n = 9) and open-label placebo (OLP; n = 9)) and a control group 
(CG; n = 10). Both the CL and the OLP groups were under a conditioned pain paradigm, in which 
they were conditioned to associate personalized heat temperatures with a sham device being ON 
or OFF, and they both received verbal suggestions about the nature and the effectiveness of the 
treatment. The CG was not conditioned, nor did they receive verbal suggestions that could lead to 
associating personalized temperatures with the sham device being ON or OFF. The CG underwent 
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sham conditioning to control for the same visual input as the experimental groups, but the colors 
were unmatched to intensities. The number of participants beginning with the sham device being 
ON or OFF was counterbalanced between the groups. Furthermore, stratification based on gender 
was applied for randomization purposes with a 75% versus 25% ratio for females and males 
respectively.  
Researchers followed validated and standard heat pain study protocols (Corsi & Colloca, 2017; 
Skvortsova, Veldhuijzen, van Middendorp, van den Bergh, & Evers, 2018) through all the sessions. 
The experiment lasted approximately two hours per participant, including 20 (sham) conditioning 
trials and six testing trials, through which two experimenters in white lab coats were there to 
conduct it at all times (Exp A and Exp B) in a standard neat room with closed windows in a room 
temperature between 20 and 25 degrees Celsius. This study was approved by the Psychology 
Research Ethics Committee (CEP19-1010/497). An overall study design is summarized in Figure 
2. 
 
Figure 2. General study design. 
2.3 Materials 
2.3.1. Questionnaires 
2.3.1.1. The short version of the State-Trait Anxiety Inventory (S-STAI; Spielberger, Gorsuch, 
Lushene, Vagg, & Jacobs, 1983) was used in order to measure state anxiety levels of individuals. 
The reliability of the six-item version of the S-STAI is 0.82 (Marteau & Bekker, 1992). Scores of 
state anxiety were measured at the beginning and the end of the study for each participant. 
2.3.1.2. The Life Orientation Test-Revised (LOT-R) (Scheier, Carver, & Bridges, 1994) 
measured optimism by assessing a total score formed by 10 items, each with a 5-point Likert scale 
(0 – strongly disagree, 4 – strongly agree). The higher the score, the higher the level of optimism 
per participant. This questionnaire was used for purposes exceeding the scope of this study. 
2.3.1.3. The Numerical Rating Scale (NRS) for pain is a subjective pain measure on which 
individuals rate their perceived pain intensities on an eleven-point numerical scale (0 = no pain at 
all; 10 = worst imaginable pain). The NRS provides sufficient discriminative power for chronic 
pain patients describing their pain intensities (Jensen, Turner, & Romano, 1994). Scores of 0.5-2 
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were considered low, 3-4.5 were considered moderate, and scores of 5.5-7 were considered high. 
During the calibration phase, we did not exceed temperatures that scored a 7 or higher on the NRS.  
2.3.2. Devices 
2.3.2.1. The PATHWAY Pain & Sensory Evaluation System was provided by the University of 
Leiden in order to induce thermal pain. The PATHWAY system allows for programmable control 
of temperature in a precise manner, using the Advanced Thermal Stimulator thermode. This 
thermode has a 30x30 mm contact with the skin and can produce temperatures between 0°C and 
55°C, with the possible change rate of 8°C per second. 
2.3.2.2. The Beurer EM80 was used as a sham device. In this study, it was referred to as the 
“(sham) external neural stimulator (ENS) device”. ENS is a lightweight programmable device with 
up to eight electrodes and four separately adjusted channels. It is a non-invasive electrical 
stimulation device that is normally used for pain therapy, muscle stimulation, and relaxation 
purposes. 
2.3.2.3. Three computers: (A) PATHWAY laptop, operated by Exp A; (B) documents 
computer (i.e., Excel sheets for NRS, eligibility sheets, questionnaire operating system), operated 
by Exp B; and (C) participant computer (for questionnaires and Psychology Software Tools, which 
were used for conditioning purposes). 
2.4 Procedure 
2.4.1. Recruitment and Participant Contact. Participants were recruited through Sona 
Systems, research recruiters, and flyers. Registration was only possible through Sona Systems, 
under the study name “Pain Personality Study”, after which participants received a confirmation 
email with an information letter about the study. All participants were sent standard email 
reminders 24 hours prior to their appointments. 
2.4.2. Randomization. An independent researcher prepared randomization envelopes, which 
were stratified by sex (female/male), to allocate each participant to one of the 6 conditions: three 
groups (CL/OLP/CG) * ENS (ON/OFF). This procedure was used in order to maximize blinding 
during testing. 
2.4.3 Study 
2.4.3.1. Introduction and eligibility requirements (15 mins): participants were first required 
to sign an informed consent form, after which demographic and eligibility information were 
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collected along with the S-STAI at the beginning of the study. Only participants who qualified for 
the study were able to carry on with the rest of the phases. 
2.4.3.2. Threshold and Calibration (40 mins): In this phase, three levels of heat stimulation 
were determined for each participant (i.e., low pain, moderate pain, and high -but bearable- pain) 
through using the PATHWAY Pain & Sensory Evaluation System and the NRS rating scale. Heat 
stimuli were applied on the dorsal side of the non-dominant arm, placing the PATHWAY thermode 
11cm from the wrist in the elbow direction with its full surface touching the skin. Tattoos and 
damaged skin were avoided. This phase was identical for all participants, as they were not yet 
assigned to specific groups. In the first part of this phase, warmth thresholds were repeatedly 
measured by asking each participant to stop the heat simulation when they first felt a change in 
temperature on the thermode, which was done by clicking the PATHWAY mouse button. Pain 
threshold measurements were conducted in a similar fashion, in which participants stopped the heat 
stimulation when they first felt pain. These procedures were conducted through one practice trial 
and three measurements each. After each measurement, participants were asked to rate their pain 
threshold on a scale from 1-10 on the NRS, which were filled in by Exp B. The thermode was 
removed after this part of the calibration phase. The second part of this phase included brief stimuli 
of different, gradually rising intensities (starting at 36°C till 50°C), after re-attaching the thermode 
on the non-dominant arm, and participants were then asked to rate their pain immediately after the 
temperature was back to baseline after each stimulus. At the end of this part the thermode was 
detached again and Exp A filled in the corresponding temperatures that the participant rated as low, 
medium, and high pain intensities in the PATHWAY program to prepare for the upcoming phase. 
In the final part of the phase, the thermode was attached to the dominant arm. This part of the 
calibration phase included applying the different personalized temperatures and checking for the 
pain ratings on the NRS for finalizing the personalized temperatures to be used in the conditioning 
and testing phase. At the end of this stage, the thermode was removed and participants were 
instructed to take a short break while the researchers set up for the next phase of the experiment.  
Each temperature peak lasted for 4 seconds, after which participants were asked to rate their 
pain intensities from 1 to 10 on NRS. During the calibration phase, any pain rating above 7 was 
considered too high and out of the scope of this study. 
2.4.3.3. ENS Instructions and Calibration (15 mins): Depending on the group they were 
assigned to, participants received different information about the ENS device and its functionality, 
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after which Exp A gave participants verbal suggestions according to their group. The OLP group 
was openly told the ENS device would be used as a sham device, and that placebo effects can have 
a large impact on pain perception. They were also told that hundreds of studies have demonstrated 
that placebo effects can influence chemical processes in the body to successfully alter pain 
perception and received further information about the placebo effect through an information sheet 
(for more details view Appendix B). Furthermore, the CP group was not told that the ENS device 
will be switched off during the experiment, but that the device can send light electrical pulses that 
can affect nerve conduction, that it decreases pain in about 92% of the people, and that they will 
probably feel less pain from the thermode (Appendix C). They further received an information 
sheet stating information about the effectivity of the ENS device. Lastly, in order to control for 
expectations, the CG was told that the ENS device will sometimes by turned on and some others 
will be turned off, and that some patients have reported to benefit from the effects of the ENS, but 
some others say that it does not alter their experience of pain. Control participants also received a 
handout containing this information (Appendix D). 
The sham device was attached to the dominant arm through two electrodes two cm from the 
elbow in the direction of the palm, and they were four cm apart. The device was set to only cause 
minor pulsations when activated to pulsation level four on electrodes CH2 in order to convince the 
participants that it was working, after which the participants, regardless of their assigned group, 
were told that researchers must find a suitable and effective ENS mode below their perception 
level, lowering the intensity until participants could not feel the pulsation anymore. In reality, the 
ENS device was then switched off. Only participants of the OLP were aware that the device was 
not on. 
2.4.3.4. Conditioning and Formal Testing (15 mins): In the conditioning part of this phase, 
20 visual cues (10 purple lights with the word ON for low pain, and 10 yellow lights with the word 
OFF for medium pain) were paired with the activation of the ENS device in the OLP and the CP 
groups. In the CG, stimuli were presented in a semi-random order along with the two colors paired 
with ON and OFF words, leading to sham conditioning. These sham trials were of 3:1 ratio of 
random color-cue allocation and planned pairing. Personalized temperatures were administered; 
namely, 10 relatively moderate pain intensities and 10 relatively low intensities. All participants 
were required to rate their pain levels on the NRS after each stimulus. Furthermore, the testing part 
of this phase included six visual cues, three yellow and three purple, three of which included the 
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word ON and three that included the word OFF (in the OLP and CP groups they corresponded with 
the colors; in the CG they were semi-randomized). However, all heat intensities were the same 
personalized medium intensity across the six cues. Differences between pain ratings in this part of 
the experiment were used as a measure for placebo effects. 
2.4.3.5. Finishing (15 mins): The ENS electrodes and the PATHWAY thermode were 
removed, and the participants were asked to fill-in the S-STAI questionnaire again as well as the 
LOT-R (which was used for an extended research project) on the participants’ computer. 
Participants were further debriefed about the actual purpose of the study, and asked to sign a 
confidentiality form necessary for further research purposes. Lastly, individuals were rewarded for 
their participation, either through study credits or a through a financial reward. 
2.5 Statistical Analysis 
Statistical analyses were conducted using the IBM Statistical Package for Social Sciences (SPSS) 
version 25 (IBM Corp., Armonk, NY, USA). To answer the research questions mentioned above, 
two mixed analyses of variance (mixed ANOVAs) were conducted. The first was to answer the 
questions of whether the placebo effect took place, and if so, whether it was specific to the placebo 
groups (i.e., OLP and CP). Based on this model, we further assessed if the OLP group had 
comparable results to the CP group regarding placebo analgesia. In the second model, we added 
the results of state anxiety levels through the use of the S-STAI results to study the effects of state 
anxiety on the placebo effect. We used post hoc tests with Bonferroni multiple testing correction 
for groups. Furthermore, a regression analysis was conducted to test the effects of state anxiety on 
the overall pain ratings (i.e., NRS scores). Moreover, a paired samples t-test was conducted to 
compare anxiety levels from the beginning and the end of the experiment to control for any increase 
in participants’ anxiousness levels at the end of the experiment. For all analyses, the level of 
statistical significance was set at p < .05.  
3. Results 
Twenty-eight individuals participated in this study, however four were excluded, three of 
whom were excluded due to program issues during the conditioning phase, and one due to personal 
response inconsistency. The OLP and the CP groups had nine participants each, and the CG had 
six. Prior to the completion of mixed analysis of variance (Mixed ANOVA), assumptions of 
sphericity, homoscedasticity, and normality were checked for, and none of them were fulfilled. 
However, statistical analyses still took place for exploratory purposes. 
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3.1 Hypotheses Testing 
Firstly, we tested whether a placebo effect took place in the study, we compared the pain ratings 
on the ENS OFF and ENS ON. Results show a significant difference between the two (p = .01; ηp2 
= .26). Furthermore, we compared groups to answer whether this was due to our placebo 
manipulation (i.e., the verbal suggestions and the conditioning) and whether this placebo effect is 
comparable between the OLP and the CP groups. Results show no overall significant group 
differences (p = .88; ηp2 = .01). Results of the two placebo hypotheses are reported in Table 1, and 
a visualization of ON and OFF scores across groups are demonstrated in Figure 2. 
Table 1. A Summary of Placebo Effects and Group Comparability. 
 Type III SS df MS F Sig. (p) ηp2 
Differences between ON and OFF 3.61 1 3.61 7.33 .01 .26 
Group Differences 0.13 2 .06 .13 .88 .01 
Error (Difference ON and OFF) 10.33 21 .49    
 
 
 
Figure 2. Scatterplot of the mean pain ratings of ENS OFF and ON across all groups. 
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In addition, to study the third hypothesis over the effects of low state anxiety on the 
placebo effect, we incorporated another between subject factor, namely the S-STAI, in the mixed 
ANOVA model stated above. Results show a non-significant effect (p = .76; ηp2 = .21), and that 
by adding the S-STAI to the model, the placebo effect in general also became non-significant (p 
= .96; ηp2 = .01).  
Furthermore, to study whether state anxiety levels had an effect on individuals’ overall pain 
ratings, namely whether highly anxious individuals scored higher on the NRS than people low on 
anxiety, we conducted a regression analysis. Results show non-significant differences, as further 
shown in Table 2.  
Table 2. Model and Coefficients Summary including S-STAI total on NRS scores. 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. (p) 
 
Variance 
B SE β R2 Adjusted R2 
 (Constant) 3.94 1.42  2.77 .01   
Total of S-STAI -0.03 0.04 -.14 -0.65 .53   
 Full Model     .53 0.02 -0.03 
3.2 Control for Anxiety Levels 
A paired samples t-test was conducted to compare means of the S-STAI levels at the beginning and 
at the end of the experiment to control for any increase in participants’ anxiety levels. Results show 
no significant differences between the first S-STAI and the second (t(21) = 0.48, p = .64) with the 
mean difference of 0.76; as stated in Table 3. 
Table 3. Summary of the Differences in Anxiety Levels at the Beginning and the End of the 
Study. 
 Paired Differences   
M SD SE Mean t df Sig. (p) (2-tailed) 
Difference in S-STAI 0.76 7.41 1.58 0.48 21 .64 
 
4. Discussion 
The current study investigated the role of state anxiety on placebo analgesia in a conditioning 
paradigm. Previous research suggests that expectancies can significantly affect the experience of 
pain either positively or negatively (Colloca & Benedetti, 2005), and expectancies of a therapeutic 
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effect in a placebo setting can be fundamental in underlying the placebo analgesic effect (Vase et 
al., 2003). Furthermore, the combined use of verbal manipulation and conditioning positively 
affects placebo analgesia. In this study, participants were subjected to thermal pain and were 
conditioned to believe that the ENS device was functional in the reduction of pain. The actual 
placebo nature of the device was only disclosed with a subgroup of the participants, namely OLPs, 
as it has been shown that long-term placebo effects can be elicited under these conditions (Blease 
et al., 2016; Charlesworth et al., 2017). Moreover, state anxiety levels of participants were 
measured prior to the experiment, as it has been hypothesized that heightened levels of state anxiety 
can lead to an increase in self-reported pain intensities (Jones et al., 2002); state anxiety was 
measured in the end once more to investigate how the experiment affected participants’ 
psychological states. In sum, we aimed to condition healthy individuals to connect pain intensities 
with color cues representing the claimed effectiveness of the ENS device, taking into consideration 
the state anxiety and nature-of-treatment awareness levels of the participants. 
Preliminary analyses show a violation of the assumptions, however we decided to continue 
with the analysis for exploratory purposes, as this the first study to use such a protocol. Researchers 
firstly checked whether the placebo effect took place or not, and it turned out that it did, as 
individuals from the placebo groups (i.e., OLP and CP) had lower pain intensity scores when the 
participant screen suggested that the sham ENS device was ON. This is in line with what we 
attempted to accomplish in order to be able to begin our analyses. Secondly, we wanted to study 
whether this effect was due to our placebo manipulation by comparing the placebo groups with the 
CG. However, we found that the placebo effect took also took place in the CG, meaning that the 
placebo effect was not solely due to the researchers’ manipulations (i.e., through conditioning and 
verbal manipulation). This could be due to the small sample size that we had in all the groups, 
leading to statistical restriction. It is also possible that we unintentionally conditioned the CG even 
though we used a 75% versus 25% ratio of screen randomization of OFF and ON color pairings; 
however, that is unlikely because there were 20 conditioning trials, which should be sufficient for 
our conditioning purposes, in line with previous studies that successfully conditioned individuals 
with similar trial numbers (Colloca, Petrovic, Wager, Ingvar, & Benedetti, 2010; Corsi & Colloca, 
2017). Furthermore, we hypothesized that individuals aware of the nature of the ENS device (i.e., 
OLP group) will experience similar placebo effects to individuals of the CP group. Results show 
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there were no group differences in placebo effects, meaning that the two groups were comparable 
in their placebo analgesic responses. 
Moreover, we tested whether anxiety levels influenced placebo analgesia in our sample, and 
results show that there were no effects. Interestingly, however, when anxiety levels were taken into 
consideration, the placebo effect was no longer evident in the statistical analysis, which could 
possibly be due to the small sample size, making the data statistically sensitive. Namely, the 
addition of an extra predictor in the statistical model without changing the sample size, especially 
when it is relatively small, makes the anxiety factor function as a positive confounder (Cohen, 
1988). We further hypothesized that individuals scoring high on state anxiety would have higher 
overall pain ratings on the NRS than individuals scoring low on state anxiety. Results showed no 
differences between individuals high in state anxiety and individuals low in state anxiety. Again, 
the small sample size could account for such results. Lastly, we controlled for any increase in state 
anxiety at the end of the experiment by comparing individual scores to state anxiety levels from 
the beginning of the study, for ethical compliance reasons. Results showed no violation of the 
standard suggesting that participants should not leave the lab feeling more negatively than when 
they arrived.  
This study’s limitations extend to its variables. Due to the small sample size, this study could 
be considered to have a highly underpowered design for the above-mentioned research purposes, 
and future research should collect further data in this field of study. The main reason behind such 
a small sample size was time limitations. Furthermore, not much information can be derived from 
this study, as statistical analyses were inconclusive due to assumption restrictions. Moreover, we 
cannot conclude much about whether conditioning fulfilled its main purpose, as it was coupled 
with verbal suggestion. This way, we could only derive whether the placebo effect took place 
without being able to distinguish which approach had more effect (conditioning or verbal 
suggestion). This makes it difficult to fully understand the reasons behind why the CG also 
demonstrated placebo analgesic effects. However, we chose this particular design as recent 
research (Bartels et al., 2014) suggests that the combination of verbal suggestion and conditioning 
has better effect on placebo effects than either of them alone, and that to increase the magnitude of 
placebo analgesic responses, it would be better to employ a combination of both (Finnis et al., 
2009). 
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Moreover, during the calibration phase, personalized moderate and low temperatures were 
calculated to be used in the conditioning and testing phases. These individualized temperatures 
were, for some participants, of a small degree difference (e.g., low: 46 degrees; moderate: 47 
degrees), and for others they were with a greater range (e.g., low: 42 degrees; high: 49.5 degrees). 
Namely, 11 participants had a temperature range less than three temperatures difference. Even 
though the scores are personalized, it is more likely that individuals experiencing a smaller range 
of temperatures would be habituated to the similar degrees, perceiving similar amounts of pain 
intensities throughout the conditioning and testing phases, affecting results of group differences.  
Altogether, it is of great importance to understand the underlying mechanisms of OLP, as this 
approach does not violate the ethical standards of administering a health treatment; namely, 
deception. One of the main strengths of this study is that it is the first to investigate the role of 
anxiety in placebo analgesia in a conditioning paradigm using the open label placebo method. 
Furthermore, this research attempted to investigate how state anxiety affects one’s responsivity to 
the application of a placebo treatment in the purpose of simulating an actual patient-professional 
interaction. Even though the results were inconclusive due to statistical restrictions, the study is the 
first of its kind to incorporate such a model, in which researchers followed very strict validated 
protocols (Corsi & Colloca, 2017; Skvortsova et al., 2018). Moreover, state anxiety levels were 
measured at the end of the study for control purposes, order for the participants not to leave the lab 
feeling more anxious than when they arrived; results show that this ethical standard was not 
violated. A further strength of this research is the diversity of the sample. Even though it was a 
very small sample, the participants were of 16 different nationalities, making the sample relatively 
heterogeneous. This cultural diversity is interesting, as it allows us to look into the various ways in 
which individuals experience and cope with pain, in line with studies suggesting that people from 
diverse cultures experience pain differently (Hocking, 1996; Peacock & Patel, 2008). A final 
strength of this research is that there were two researchers in the lab with the participants at all 
times, easing the complex implementation of the protocol and eliminating researcher bias.  
Due to the above-mentioned reasons, this experiment could be considered a pilot study to a 
more strongly developed design. The main aspect to be further developed is the sample size, which 
can be attained through having sufficient data collection time, financial support, and more efficient 
recruitment methods (e.g., online advertising). Future research using this as a pilot study could 
make use of expanding this research to look into how the effects of people’s general anxiety levels 
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(i.e., trait anxiety) are connected to their placebo and conditioning responsivity. Additionally, in 
this study, we attempted to compare individuals high in anxiety to ones low in anxiety due to the 
higher contrast and to make the sample more comparable to pain patients suffering from anxiety. 
This rationale is based on evidence suggesting that anxiety disorder affects 25% of pain populations 
(Polatin, Kinney, Gatchel, Lillo, & Mayer, 1993), whereas it affects 8.8% of the general population 
(Blazer, Kessler, McGonagle, & Swartz, 1994). However, it would be of interest to include 
moderate anxiety scores in the comparison, as the number of individuals scoring in the moderate 
range in this paper was comparable to the number of individuals in the high range. Future studies 
can also manipulate state levels of anxiety in order to have more balanced sample numbers within 
the state anxiety variable, which could achieve better statistical inferences by decreasing the rate 
of statistical assumption violations.  Moreover, future research could look into the extent that verbal 
suggestion alone can influence placebo analgesia and pain perception in individuals scoring high 
on anxiety, as verbal suggestion alone is more applicable in a realistic clinical setting. Research 
based on this pilot study can explicitly measure the belief in the administered placebo for further 
control purposes. The limitations of this study were partly expected as it is the first of its kind to 
combine many different factors, such as state anxiety and conditioning, into one experiment in the 
field of placebo analgesia of thermal pain. Even though not many statistical inferences took place 
in this paper, it can still have a large positive impact on this field of study, as future research can 
enhance upon the limitations and can make use of the process implemented.  
In sum, this study investigated the influence of state anxiety on placebo analgesic responses 
within a conditioning paradigm, taking into account the level of knowledge that individuals have 
concerning the nature of the treatment that they received (open-label or not). This is the first study 
to incorporate variables within one protocol, thus its strengths and limitations cause one to consider 
it a pilot study, leading future research to be more conclusive of the collected data. 
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Appendix A 
The Short Version of the State-Trait Anxiety Inventory (Spielberger, Gorsuch, Lushene, Vagg, & 
Jacobs, 1983) 
A number of statements which people have used to describe themselves are given below. Read 
each statement and then choose the most appropriate option to the right of the statement to indicate 
how you feel right now, at this moment. There are no right or wrong answers. Do not spend too 
much time on any one statement but give the answer which seems to describe you present feelings 
best. 
 
 
Not at all Somewhat Moderately 
Very 
much 
     
I feel calm 1 2 3 4 
I am tense 1 2 3 4 
I feel upset 1 2 3 4 
I am relaxed 1 2 3 4 
I feel content 1 2 3 4 
I am worried 1 2 3 4 
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Appendix B 
Information Sheet Given to the OLP Group 
Electrical nerve stimulation (ENS) can decrease pain 
What is ENS? 
Electrical Nerve Stimulation (ENS) is the 
administration of an electric current produced by a 
special device that can affect nerve fibres. ENS 
decreases nerve conduction.  
Scientific research found support for the 
effectiveness of ENS for chronic numbness of the 
lower limbs, lateral epicondylitis (tennis elbow), 
and carpal tunnel syndrome (Chesterton et al., 
2016; Koca, Boyaci, Tutoglu, Ucar, & Kocaturk, 2017; Mulvey, Fawkner, Radford, & Johnson, 
2016).  
How does ENS affect pain?  
Heat pain is decreased by ENS through nerve fibre conductivity. Indeed, nerve fibres in the skin 
communicate what is perceived via electrical signals. When these signals are sent to the spinal 
cord and brain, we become aware of the pain sensations. ENS stimulation can influence this 
conductivity process by decreasing the intensity of incoming signals. This means that pain caused 
by stimuli applied on the skin, such as heat stimuli, can be decreased by this device (Chen & 
Johnson, 2017;  Schliessbach, Klift, Arendt-nielsen, Curatolo, & Streitberger, 2016). 
ENS decreases pain  
ENS treatment has repeatedly been found to decrease pain from heat, as a side effect of decreased 
nerve conduction (Vance, Dailey, Rakel, & Sluka, 2017). A recent study showed that 92% of the 
participants reported substantially lower pain when they received heat stimuli during ENS (Ellrich 
& Lamp, 2017). 
Sub perception stimulation 
Some studies shown that slight electrical pulses, below the perception level, can modulate deep 
electrical signal conduction (Chen & Johnson, 2017, 2018). So clinically, a big advantage of ENS 
is that an (almost) imperceptible stimulation is sufficient to affect electrical conduction and thus 
reduce the perceived pain (Ellrich & Lamp, 2017). 
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PAIN PERCEPTION AND PLACEBO EFFECTS 
The Placebo Effect 
Now, some more information follows about the purpose of this study. This study focuses on 
placebo effects. Placebo effects are a common phenomenon in scientific research and clinical 
practice.  
In treatment studies, overall treatment effects are the result of two 
mechanisms:  
 The treatment effect itself  (red bar in figure); 
 The placebo effect (blue bars in figure) which is dependent on 
factors such as previous experience, expectations and the physician-
patient interaction.  
As you can see in the picture, the placebo effect has a large influence in 
the total treatment effect. Placebo effects can thus increase therapeutic 
effects.  
 
 
How do placebos work? 
 Expectations have a big impact 
on treatment outcomes. If you 
have positive expectations, they 
may develop a more positive 
treatment outcome and affect your 
pain experience in this present 
study. You may not only feel 
better from the procedure itself, 
but also because you expect to 
feel better.  
 Positive expectations also affect processes in your body. When you have positive 
expectations, the brain produces chemicals. These chemical substances are called 
neurotransmitters and can make you feel better. Placebos can also trigger the release of 
neurotransmitters. In this study we will be making use of these processes to reduce pain. 
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In this study we want to induce placebo effects with the ENS device. The device will be 
switched off during the experiment, but it is definitely possible that you experience less pain 
because of placebo effects.  
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Appendix C 
Information Sheet Given to the CP Group 
Electrical nerve stimulation (ENS) can decrease pain 
What is ENS? 
Electrical Nerve Stimulation (ENS) is the 
administration of an electric current produced by a 
special device that can affect nerve fibers. ENS 
decreases nerve conduction.  
Scientific research found support for the effectiveness 
of ENS for chronic numbness of the lower limbs, 
lateral epicondylitis (tennis elbow), and carpal tunnel 
syndrome (Chesterton et al., 2016; Koca, Boyaci, Tutoglu, Ucar, & Kocaturk, 2017; Mulvey, 
Fawkner, Radford, & Johnson, 2016).  
How does ENS affect pain?  
Heat pain is decreased by ENS through nerve fiber conductivity. Indeed, nerve fibers in the skin 
communicate what is perceived via electrical signals. When these signals are sent to the spinal 
cord and brain, we become aware of the pain sensations. ENS stimulation can influence this 
conductivity process by decreasing the intensity of incoming signals. This means that pain caused 
by stimuli applied on the skin, such as heat stimuli, can be decreased by this device (Chen & 
Johnson, 2017;  Schliessbach, Klift, Arendt-nielsen, Curatolo, & Streitberger, 2016). 
ENS decreases pain  
ENS treatment has repeatedly been found to decrease pain from heat, as a side effect of decreased 
nerve conduction (Vance, Dailey, Rakel, & Sluka, 2017). A recent study showed that 92% of the 
participants reported substantially lower pain when they received heat stimuli during ENS (Ellrich 
& Lamp, 2017). 
Sub perception stimulation 
Some studies shown that slight electrical pulses, below the perception level, can modulate deep 
electrical signal conduction (Chen & Johnson, 2017, 2018). So, clinically, a big advantage of 
ENS is that an (almost) imperceptible stimulation is sufficient to affect electrical conduction and 
thus reduce the perceived pain (Ellrich & Lamp, 2017). 
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Appendix D 
Information Sheet Given to the CG 
Electrical nerve stimulation (ENS) 
What is ENS? 
Electrical Nerve Stimulation (ENS) is the 
administration of an electric current produced by 
a special device that can affect nerve fibers.  
Can ENS affect pain?  
Nerve fibers in the skin communicate what is 
perceived via electrical signals. When these 
signals are sent to the spinal cord and brain, we 
become aware of the pain sensations. Because ENS induces stimulations, this may have an effect 
on the intensity of incoming pain signals. Few studies have examined this. Some patients have 
reported to benefit from the effects of ENS, but other patients report that it doesn’t make any 
difference in their experience of pain. With this study, we will investigate whether there is 
support or not for this conductivity theory.  
Sub perception stimulation 
Some studies show that slight electrical pulses, below the perception level, can modulate deep 
electrical signal conduction. This study will measure (almost) imperceptible stimulations. 
 
 
